All Mylan's medicines in Australia have been evaluated by the Therapeutic Goods Administration (TGA). Mylan's generic medicines are equivalent in terms of efficacy, dosage, safety, strength and quality, providing patients with the same therapeutic benefits as the initial registered medicine1.
Why choose a generic?
Generic medicines are often a more affordable choice for many patients. They drive savings that help ensure the sustainability of the government subsidised Pharmaceutical Benefits Scheme (PBS).
Every time a generic medicine is dispensed it can contribute savings to the nation, and make available funds for new, more expensive medicines needed to better manage diseases like cancer, diabetes and Alzheimer’s disease2
1. Therapeutic Goods Administration Accessed July 2016: www.tga.gov.au/australian-regulation-prescription-medical-products
2. GBMA: Generics Medicines Facts Accessed July 2016 www.gbma.com.au/generic-facts/